This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6ehw
From Proteopedia
(Difference between revisions)
m (Protected "6ehw" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery== | |
| - | + | <StructureSection load='6ehw' size='340' side='right' caption='[[6ehw]], [[Resolution|resolution]] 2.19Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6ehw]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6EHW OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6EHW FirstGlance]. <br> | |
| - | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ehw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ehw OCA], [http://pdbe.org/6ehw PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ehw RCSB], [http://www.ebi.ac.uk/pdbsum/6ehw PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ehw ProSAT]</span></td></tr> | |
| - | [[ | + | </table> |
| + | __TOC__ | ||
| + | </StructureSection> | ||
[[Category: Hargreaves, D]] | [[Category: Hargreaves, D]] | ||
| + | [[Category: Abvance]] | ||
| + | [[Category: Immune system]] | ||
| + | [[Category: Pistoia alliance]] | ||
| + | [[Category: Scfv]] | ||
Revision as of 07:56, 8 November 2017
scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery
| |||||||||||
